We conducted a comprehensive comparison of the diagnostic value of traditional inflammatory biomarkers (CRP and ESR), fibrinolytic biomarkers (fibrinogen and D-dimer), and previously established biomarkers (CAR, CLR, and CMR) in PJI patients, considering their obesity status. This evidence concerns the gene CRP and juvenile polyposis syndrome.